Target Price | $8.45 |
Price | $4.45 |
Potential |
89.99%
register free of charge
|
Number of Estimates | 11 |
11 Analysts have issued a price target Health Catalyst Inc 2026 .
The average Health Catalyst Inc target price is $8.45.
This is
89.99%
register free of charge
$16.00
259.55%
register free of charge
$5.00
12.36%
register free of charge
|
|
A rating was issued by 13 analysts: 10 Analysts recommend Health Catalyst Inc to buy, 3 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Health Catalyst Inc stock has an average upside potential 2026 of
89.99%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 306.58 | 334.49 |
3.60% | 9.10% | |
EBITDA Margin | -4.34% | 12.05% |
68.29% | 377.35% | |
Net Margin | -24.02% | -16.92% |
46.89% | 29.56% |
13 Analysts have issued a sales forecast Health Catalyst Inc 2025 . The average Health Catalyst Inc sales estimate is
This results in the following potential growth metrics:
13 Analysts have issued an Health Catalyst Inc EBITDA forecast 2025. The average Health Catalyst Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 Health Catalyst Inc Analysts have issued a net profit forecast 2025. The average Health Catalyst Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.15 | -0.88 |
44.98% | 23.48% | |
P/E | negative | |
EV/Sales | 0.96 |
9 Analysts have issued a Health Catalyst Inc forecast for earnings per share. The average Health Catalyst Inc EPS is
This results in the following potential growth metrics and future valuations:
Health Catalyst Inc...
Analyst | Rating | Action | Date |
---|---|---|---|
Stephens & Co. |
Locked
➜
Locked
|
Locked | Mar 06 2025 |
RBC Capital |
Locked
➜
Locked
|
Locked | Feb 27 2025 |
Stephens & Co. |
Locked
➜
Locked
|
Locked | Feb 27 2025 |
Stifel |
Locked
➜
Locked
|
Locked | Feb 27 2025 |
Piper Sandler |
Locked
➜
Locked
|
Locked | Feb 11 2025 |
Wells Fargo |
Locked
➜
Locked
|
Locked | Jan 21 2025 |
Canaccord Genuity |
Locked
➜
Locked
|
Locked | Jan 21 2025 |
Analyst Rating | Date |
---|---|
Locked
Stephens & Co.:
Locked
➜
Locked
|
Mar 06 2025 |
Locked
RBC Capital:
Locked
➜
Locked
|
Feb 27 2025 |
Locked
Stephens & Co.:
Locked
➜
Locked
|
Feb 27 2025 |
Locked
Stifel:
Locked
➜
Locked
|
Feb 27 2025 |
Locked
Piper Sandler:
Locked
➜
Locked
|
Feb 11 2025 |
Locked
Wells Fargo:
Locked
➜
Locked
|
Jan 21 2025 |
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Jan 21 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.